BACKGROUND: Pathogenic infection with human immunodeficiency virus type 1 (HIV-1) or simian immunodeficiency virus (SIV) is characterized by a loss of CD4+ T cells and chronic lymphocyte activation even during suppressive antiretroviral therapy (ART). METHODS: Using NanoString, expression of >100 molecules associated with inflammation or immune activation was evaluated in mesenteric lymph nodes and ileum of macaques infected with a pathogenic SIV/HIV virus, RT-SHIV, during viremia or during suppressive ART and compared to uninfected controls. RESULTS: Of the 105 RNA species quantified in the tissues, expression of 33 genes was altered significantly in one or both tissues during viremia but returned to normal levels during ART. However, 29 additional genes were altered in expression levels in the tissues of both viremic and ART-suppressed macaques. CONCLUSIONS: Identification of the mechanisms of chronic inflammation in specific cells and in different tissues may help determine whether early ART initiation or novel therapies can prevent it.
BACKGROUND: Pathogenic infection with human immunodeficiency virus type 1 (HIV-1) or simian immunodeficiency virus (SIV) is characterized by a loss of CD4+ T cells and chronic lymphocyte activation even during suppressive antiretroviral therapy (ART). METHODS: Using NanoString, expression of >100 molecules associated with inflammation or immune activation was evaluated in mesenteric lymph nodes and ileum of macaques infected with a pathogenic SIV/HIV virus, RT-SHIV, during viremia or during suppressive ART and compared to uninfected controls. RESULTS: Of the 105 RNA species quantified in the tissues, expression of 33 genes was altered significantly in one or both tissues during viremia but returned to normal levels during ART. However, 29 additional genes were altered in expression levels in the tissues of both viremic and ART-suppressed macaques. CONCLUSIONS: Identification of the mechanisms of chronic inflammation in specific cells and in different tissues may help determine whether early ART initiation or novel therapies can prevent it.
Authors: Timothy W Schacker; Phuong L Nguyen; Esteban Martinez; Cavan Reilly; Jose M Gatell; Andrzej Horban; Elzbieta Bakowska; Baiba Berzins; Remko van Leeuwen; Steven Wolinsky; Ashley T Haase; Robert L Murphy Journal: J Infect Dis Date: 2002-09-20 Impact factor: 5.226
Authors: Saurabh Mehandru; Michael A Poles; Klara Tenner-Racz; Victoria Manuelli; Patrick Jean-Pierre; Peter Lopez; Anita Shet; Andrea Low; Hiroshi Mohri; Daniel Boden; Paul Racz; Martin Markowitz Journal: J Virol Date: 2006-10-25 Impact factor: 5.103
Authors: R S Veazey; M DeMaria; L V Chalifoux; D E Shvetz; D R Pauley; H L Knight; M Rosenzweig; R P Johnson; R C Desrosiers; A A Lackner Journal: Science Date: 1998-04-17 Impact factor: 47.728
Authors: Peter W Hunt; Jeffrey N Martin; Elizabeth Sinclair; Barry Bredt; Elilta Hagos; Harry Lampiris; Steven G Deeks Journal: J Infect Dis Date: 2003-04-23 Impact factor: 5.226
Authors: Patricia Polacino; Brad Cleveland; Yongde Zhu; Jason T Kimata; Julie Overbaugh; David Anderson; Shiu-Lok Hu Journal: J Med Primatol Date: 2007-08 Impact factor: 0.667
Authors: Jason M Brenchley; David A Price; Timothy W Schacker; Tedi E Asher; Guido Silvestri; Srinivas Rao; Zachary Kazzaz; Ethan Bornstein; Olivier Lambotte; Daniel Altmann; Bruce R Blazar; Benigno Rodriguez; Leia Teixeira-Johnson; Alan Landay; Jeffrey N Martin; Frederick M Hecht; Louis J Picker; Michael M Lederman; Steven G Deeks; Daniel C Douek Journal: Nat Med Date: 2006-11-19 Impact factor: 53.440
Authors: Irini Sereti; Jacob D Estes; William L Thompson; David R Morcock; Margaret A Fischl; Thérèse Croughs; Stéphanie Beq; Sylvie Lafaye de Micheaux; Michael D Yao; Alexander Ober; Eleanor M P Wilson; Ven Natarajan; Hiromi Imamichi; Mohamed R Boulassel; Michael M Lederman; Jean-Pierre Routy Journal: PLoS Pathog Date: 2014-01-30 Impact factor: 6.823
Authors: Kevin Melody; Sarah McBeth; Christopher Kline; Angela D M Kashuba; John W Mellors; Zandrea Ambrose Journal: Antimicrob Agents Chemother Date: 2015-10-05 Impact factor: 5.191
Authors: Daria Van Tyne; Yan Tan; Johanna P Daily; Steve Kamiza; Karl Seydel; Terrie Taylor; Jill P Mesirov; Dyann F Wirth; Danny A Milner Journal: Genome Med Date: 2014-11-29 Impact factor: 11.117